A phase II single‐arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effects - Concepedia

Concepedia

Publication | Open Access

A phase II single‐arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effects

DOI Full Paper Access

19

Citations

54

References

2023

Year

Zev M. Nakamura, Allison M. Deal, Eliza M. Park, Kate E. Stanton, Yesy E. Lopez, Laura J. Quillen, Erin O’Hare Kelly, Hillary Heiling, Kirsten A. Nyrop, Emily M. Ray,

Cancer Medicine

Abstract

ClinicalTrials.gov NCT04033419.

References

	Year	Citations

Page 1